UniProt ID | LCK_MOUSE | |
---|---|---|
UniProt AC | P06240 | |
Protein Name | Proto-oncogene tyrosine-protein kinase LCK | |
Gene Name | Lck | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 509 | |
Subcellular Localization |
Cytoplasm . Cell membrane Lipid-anchor Cytoplasmic side . Present in lipid rafts in an inactive form. |
|
Protein Description | Non-receptor tyrosine-protein kinase that plays an essential role in the selection and maturation of developing T-cells in the thymus and in the function of mature T-cells. Plays a key role in T-cell antigen receptor (TCR)-linked signal transduction pathways. Constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, thereby recruiting the associated LCK protein to the vicinity of the TCR/CD3 complex. LCK then phosphorylates tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the cytoplasmic tails of the TCR-gamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. Once stimulated, the TCR recruits the tyrosine kinase ZAP70, that becomes phosphorylated and activated by LCK. Following this, a large number of signaling molecules are recruited, ultimately leading to lymphokine production. LCK also contributes to signaling by other receptor molecules. Associates directly with the cytoplasmic tail of CD2, which leads to hyperphosphorylation and activation of LCK. Also plays a role in the IL2 receptor-linked signaling pathway that controls the T-cell proliferative response. Binding of IL2 to its receptor results in increased activity of LCK. Is expressed at all stages of thymocyte development and is required for the regulation of maturation events that are governed by both pre-TCR and mature alpha beta TCR. Phosphorylates other substrates including RUNX3, PTK2B/PYK2, the microtubule-associated protein MAPT, RHOH or TYROBP (By similarity). Interacts with UNC119; this interaction plays a crucial role in activation of LCK (By similarity).. | |
Protein Sequence | MGCVCSSNPEDDWMENIDVCENCHYPIVPLDSKISLPIRNGSEVRDPLVTYEGSLPPASPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHDLVRHYTNASDGLCTKLSRPCQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLNVNKLLDMAAQIAEGMAFIEEQNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYHLMMLCWKERPEDRPTFDYLRSVLDDFFTATEGQYQPQP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGCVCSSNP ------CCCCCCCCC | 16.74 | 7980442 | |
3 | S-palmitoylation | -----MGCVCSSNPE -----CCCCCCCCCC | 2.42 | 8524258 | |
5 | S-palmitoylation | ---MGCVCSSNPEDD ---CCCCCCCCCCCC | 4.25 | 8524258 | |
35 | Phosphorylation | VPLDSKISLPIRNGS EECCCCCEEEECCCC | 31.65 | 22817900 | |
42 | Phosphorylation | SLPIRNGSEVRDPLV EEEECCCCCCCCCEE | 36.15 | 22817900 | |
59 | Phosphorylation | EGSLPPASPLQDNLV CCCCCCCCCCCCCEE | 31.73 | 22817900 | |
94 | Phosphorylation | QLRILEQSGEWWKAQ EEEEEEECCCCEEEE | 29.33 | 28833060 | |
102 | Phosphorylation | GEWWKAQSLTTGQEG CCCEEEEECCCCCCC | 32.32 | 25266776 | |
121 | Phosphorylation | NFVAKANSLEPEPWF HHEEECCCCCCCCCH | 38.68 | 27600695 | |
158 | Phosphorylation | FLIRESESTAGSFSL EEEEECCCCCCEEEE | 32.60 | 28833060 | |
159 | Phosphorylation | LIRESESTAGSFSLS EEEECCCCCCEEEEE | 30.87 | 28833060 | |
162 | Phosphorylation | ESESTAGSFSLSVRD ECCCCCCEEEEEEEE | 14.81 | - | |
164 | Phosphorylation | ESTAGSFSLSVRDFD CCCCCEEEEEEEEEC | 22.79 | 19060867 | |
192 | Phosphorylation | NLDNGGFYISPRITF ECCCCCEEECCCEEC | 12.08 | 20438120 | |
194 | Phosphorylation | DNGGFYISPRITFPG CCCCEEECCCEECCC | 9.21 | 27600695 | |
198 | Phosphorylation | FYISPRITFPGLHDL EEECCCEECCCHHHH | 25.67 | 28833060 | |
394 | Phosphorylation | RLIEDNEYTAREGAK HHHCCCCCCCCCCCC | 16.38 | 7521333 | |
395 | Phosphorylation | LIEDNEYTAREGAKF HHCCCCCCCCCCCCC | 17.04 | 27566939 | |
499 | Phosphorylation | SVLDDFFTATEGQYQ HHHHHHHHHCCCCCC | 32.44 | 28833060 | |
505 | Phosphorylation | FTATEGQYQPQP--- HHHCCCCCCCCC--- | 32.77 | 7521333 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
59 | S | Phosphorylation | Kinase | ERK-SUBFAMILY | - | GPS |
394 | Y | Phosphorylation | Kinase | LCK | P06240 | PSP |
505 | Y | Phosphorylation | Kinase | CSK | P41241 | Uniprot |
505 | Y | Phosphorylation | Kinase | LCK | P06240 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LCK_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LCK_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CYLD_MOUSE | Cyld | physical | 16501569 | |
SOCS6_MOUSE | Socs6 | physical | 20007709 | |
LCK_HUMAN | LCK | physical | 20360068 | |
P85A_MOUSE | Pik3r1 | physical | 9115297 | |
CBL_MOUSE | Cbl | physical | 9115297 | |
DLG1_MOUSE | Dlg1 | physical | 15699074 | |
ZAP70_MOUSE | Zap70 | physical | 15699074 | |
WASP_MOUSE | Was | physical | 15699074 | |
AES_HUMAN | AES | physical | 26496610 | |
APOE_HUMAN | APOE | physical | 26496610 | |
ATP5I_HUMAN | ATP5I | physical | 26496610 | |
MEN1_HUMAN | MEN1 | physical | 26496610 | |
SPAST_HUMAN | SPAST | physical | 26496610 | |
YES_HUMAN | YES1 | physical | 26496610 | |
CDK13_HUMAN | CDK13 | physical | 26496610 | |
C2CD5_HUMAN | C2CD5 | physical | 26496610 | |
HPS5_HUMAN | HPS5 | physical | 26496610 | |
CAMP2_HUMAN | CAMSAP2 | physical | 26496610 | |
NELFD_HUMAN | NELFCD | physical | 26496610 | |
ZBED8_HUMAN | ZBED8 | physical | 26496610 | |
PHF5A_HUMAN | PHF5A | physical | 26496610 | |
ESCO1_HUMAN | ESCO1 | physical | 26496610 | |
NSE2_HUMAN | NSMCE2 | physical | 26496610 | |
CBLB_MOUSE | Cblb | physical | 26416283 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Palmitoylation | |
Reference | PubMed |
"Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif."; Koegl M., Zlatkine P., Ley S.C., Courtneidge S.A., Magee A.I.; Biochem. J. 303:749-753(1994). Cited for: PALMITOYLATION AT CYS-3 AND CYS-5, MYRISTOYLATION AT GLY-2, ANDMUTAGENESIS OF GLY-2; CYS-3 AND CYS-5. | |
"Palmitylation of an amino-terminal cysteine motif of protein tyrosinekinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins."; Shenoy-Scaria A.M., Timson L.K., Kwong J., Shaw A.S., Lublin D.M.; Mol. Cell. Biol. 13:6385-6392(1993). Cited for: PALMITOYLATION AT CYS-3 AND CYS-5, AND MUTAGENESIS OF CYS-3 AND CYS-5. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-394, AND MASSSPECTROMETRY. |